INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Sep 17, 2003 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 678
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 87,060 | -- | -- |
| Sep 17, 2003 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 678
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 5,000 | $4.00 | 59,540 |
| Sep 17, 2003 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 678
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 954 | $20.95 | 58,586 |
| Sep 17, 2003 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 678
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 34,250 | $4.25 | 92,836 |
| Sep 17, 2003 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 678
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 6,948 | $20.95 | 85,888 |
| Sep 17, 2003 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 678
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 87,060 | $4.25 | 172,948 |
| Sep 17, 2003 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 678
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 17,661 | $20.95 | 155,287 |
| Sep 17, 2003 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 678
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 24,636 | $20.95 | 130,651 |
| Sep 17, 2003 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 678
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Open market or private sale of non-derivative or derivative security | 17,000 | $20.25 | 113,651 |
| Sep 17, 2003 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 678
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Open market or private sale of non-derivative or derivative security | 2,400 | $20.26 | 111,251 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.